US › Healthcare

Cosmos Health Inc. (COSM)

US · Healthcare · Medical Distribution

$0.22-4.68%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$17.9M
Revenue YoY
+30.7%
Net profit
$-2.8M
Profit YoY
-242.9%
EPS
$-0.36
EPS estimate
$-0.04
Net margin
-15.6%

EPS came in at -0.36 against a street estimate of -0.04 — a miss of 800.0%.

Key statistics

Market cap
$13.4M
Forward P/E
21.1
P/B
0.66
Book value
$0.40
EPS (TTM)
$-0.66
52-week high
$1.32
52-week low
$0.16
50-day MA
$0.23
200-day MA
$0.43
Beta
4.15

Analyst view

Analysts rate Cosmos Health Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $4.50.

Shareholding

Insiders
33.98%
Institutions
5.12%

Largest institutional holders

FundStake
Renaissance Technologies Corp0.63%
Geode Capital Management, LLC0.51%
BlackRock Inc0.43%
Vanguard Group Inc0.38%
Vanguard Capital Management, LLC0.23%
Vanguard Fiduciary Trust Co0.15%
HRT FINANCIAL LLC0.11%
State Street Corp0.07%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Cosmos Health Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.